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Abstract
Infective endocarditis is defined by a focus of infection within the heart. Despite
the optimal care, the mortality approaches 30% at 1 year, so the care for this type of
patients represents a challenge to improve the result in your care. The challenges in
this clinical entity have several aspects such as the diversity of germs that cause
endocarditis, and the most important epidemiologically has generated resistance to
antimicrobial treatment along with the possibility of apoptosis in their host-germ
interaction. The immunogenetic susceptibility to host infection is discussed, which
represents a deep area of research. Inflammation, local and systemic, is complex,
with the genesis of reactive oxygen species, which are harmful when the antioxi-
dant defenses are exceeded, causing the break in the mitochondrial electron trans-
port chain with the fall in energy genesis, multiple organ failure, and death. Both at
the cellular level and in the mitochondria, possible therapeutic targets are also
commented.
Keywords: infective endocarditis, Staphylococcus aureus, single nucleotide
polymorphism (SNP), inflammatory response, reactive oxygen species (ROS),
oxidative stress, multiple organ failure (MOF)
1. Introduction
In this chapter we will analyze the physiopathological changes involved in the
inflammatory response of the septic process in infective endocarditis [IE] that
culminate with cellular damage and the generation of organic failures; morpholog-
ical changes, cellular biology, biochemistry, immunology, and genetic vulnerability,
which together are called “pathobiology,” are the substrate of clinical manifesta-
tions of this serious disease, which requires a multidisciplinary group of experts
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(cardiologists, infectologists, surgeons, intensivists) to optimize therapeutic
approach. IE is defined as a severe multisystem disease, which results from an
infection, often bacterial, that initially affects the endocardial surface of the heart
[1]. The epidemiological pattern has changed over time [2–4]. The incidence has
increased in recent years to 5–10 cases per 100,000 inhabitants [2], due to the fact
of a greater number of predisposing factors such as the use of permanent cardio-
vascular devices, invasion with intravenous catheters in critical care units, and
hemodialysis treatments, in addition to having greater accessibility to diagnostic
tools. From the etiological point of view, Staphylococcus aureus (S. aureus) is pre-
dominant as a causal germ [5, 6]. The clinical course of a patient with IE depends on
the inflammatory response, since it is variable; it also depends on the germ and the
response of the patient to infection with varying degrees of hemodynamic and
metabolic compromise [7–9]. We emphasize the current trend of the search for
organic failures associated to the septic processes for their identification and strat-
ification and therapeutic approach [10]. Given the characteristics of the disease,
IE has a high mortality that goes from 20 to 30% in the reported series [2, 11]; it is
noteworthy that the evolution toward septic shock has been documented in
30% [12], considering this complication as an independent variable of poor
prognosis [13].
2. Epidemiology of infective endocarditis
The pathogenesis and the prognosis of IE can be simply described in a general
way as the interaction between the host and the germ; however, these factors are
not independent and are very importantly linked both in the susceptibility charac-
teristics of the host (advanced age, higher prevalence of comorbid conditions, and
exposure to health care) to survive or not to an infectious state, as of the character-
istics of the germ involved. To reduce the incidence of IE and improve its outcome,
epidemiological studies can provide valuable information on contemporary and
modifiable risks to modify their morbidity and mortality [14].
The incidence of hospital discharge diagnoses for drug dependence combined
with IE increased more than twelvefold from 0.2 to 2.7 per 100,000 persons per
year over this 6-year period. Correspondingly, hospital costs for these patients
increased eighteenfold, from $1.1 million in 2010 to $22.2 million in 2015 [15].
In another study also conducted in the USA, using a national sample of hospi-
talized patients from 1998 to 2009 with focus on IE showed an increase in the use of
intracardiac devices from 13.3 to 18.9%. In cases with pathogens identified, S. aureus
was the most common, increasing from 37.6% in 1998 to 49.3% in 2009, 53.3% of
which were methicillin-resistant Staphylococcus aureus (MRSA) [16]. The above can
give us an idea of the economic and assistance impact of treating patients with
severe sepsis such as IE. It is an infection inside the organ that is responsible for
distributing blood to practically the whole organism.
The evolution of an inflammatory process plus infection frequently occurs with
clinical manifestations unspecified such as fever or hypothermia, tachycardia,
tachypnea, or abnormal white blood cell count, progressing to septic shock and
acute organ failure [17].
Epidemiological data of more than five decades tell us that S. aureus is the most
important causal agent of IE [4]; so in the development of systemic inflammation
that is generated by the host-germ interaction, we will consider the S. aureus as the
best example of IE due to its virulence and an emergent property that we know as
resistance to antibiotics, sophisticated defense mechanisms, and the ability to cause
apoptosis in cells when it is alive inside the cell. The interaction of S. aureus-host
allows us to develop in a substantive way, on one hand, the importance of the
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virulence of the germ and, on the other, the defense mechanisms of the host,
showing how the inflammation is generated and amplified to offer a step to oxida-
tive stress. It is important to mention that other agents can cause IE such as strep-
tococci and fungi.
3. Staphylococcus aureus
S. aureus is a Gram-positive coccus with a diameter of 0.5–1.5 μm, grouped as
single cells, in pairs, tetrads, short chains, or forming a conglomerate in a cluster of
grapes. This microorganism was first described in the year 1880, in Aberdeen,
Scotland, by the surgeon Alexander Ágoston. The name comes from the Greek
σταφυλόκοκκος, which is composed of the terms “staphylé,” meaning cluster, and
coccus, meaning grain or grape, and from the Latin “aureus” which means golden,
that is to say “cluster of golden grapes.”
They are non-motile bacteria, not sporulated, with no capsule (although there
are some strains that develop a slime capsule); they are facultative anaerobes. Most
staphylococci produce catalase (enzyme capable of dismutating hydrogen peroxide
in H2O + O2), characteristic that is used to differentiate its sort from others like
Streptococcus and Enterococcus. In 1961, the first report was made on the existence of
a methicillin-resistant Staphylococcus aureus [18].
3.1 Staphylococcus aureus and endothelial cell
S. aureus is a pathogen that causes significant morbidity and mortality world-
wide [2]. It is the leading pathogen associated with life-threatening bloodstream
infections [19].
Although S. aureus is mainly known as an extracellular pathogen, it has been
shown to invade and survive within endothelial cells, both within vacuoles and free
in the cytoplasm, which implies that the bacteria can escape from the
phagolysosome. S. aureus tends to infect endovascular tissue. It is believed that this
ability contributes to causing a persistent endovascular infection with endothelial
destruction.
3.2 Endothelial cell and Staphylococcus aureus ingestion
On the other hand, the death of endothelial cells after the invasion of S. aureus
occurs at least in part by apoptosis, as demonstrated by DNA fragmentation and
changes in nuclear morphology. Apoptotic changes are observed as early as 1 h after
infection of endothelial cells [18]; they are considered to function as
nonprofessional phagocytes, being able to ingest S. aureus [20, 21] following the
adhesion of this to endothelial cell monolayers; invasion can occur through inges-
tion by endothelial cells.
For the internalization of S. aureus, adherence seems to be necessary, since the
use of the phagocytosis inhibitor cytochalasin D prevented apoptosis. Studies show
that living intracellular S. aureus induces apoptosis of endothelial cells and that this
depends on a factor associated with viable organisms, since dead S. aureus (by
ultraviolet light) also internalized does not induce it [18]. The process has been
observed through electron transmission micrographs of bovine aortic endothelial
cell monolayers infected with S. aureus, showing phagocytosis following a sequence
of events: (I) adhesion of S. aureus to the endothelial cell, (II) formation of cup-
shaped processes on the surface of the endothelial cell underlying the adherent
bacteria, and (III) elongation of the cup and engulfment of bacteria within a
phagosome [19].
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3.3 Heme prosthetic group and Staphylococcus aureus
To colonize a vertebrate host, S. aureus requires numerous nutrients, such as the
prosthetic group heme. The requirement can be met through two distinct mecha-
nisms: importing exogenous heme through dedicated machinery or synthesizing
endogenous heme from own metabolic precursors. These two mechanisms are
necessary for a complete virulence of S. aureus [22, 23]. Once acquired, heme is used
for several cell processes. The intact heme is used as a cofactor for enzymes [24],
including cytochromes in the electron transport chain, catalase for the detoxifica-
tion of reactive oxygen species, and bacterial nitric oxide synthase (bNOS).
Although the S. aureus requires heme, its excess is toxic to the germ, so it has a
mechanism for hem detoxification through a hem sensor system (HssRS) that
induces the expression of a hem regulator transporter (hrtAB) [25]. The suppres-
sion of the components of this route affects the virulence of S. aureus. This ability to
detoxify heme is critical to survive in the host. Also, the synthesis of nitric oxide is
important for the bacteria to survive. Bacteria encode genes similar to nitric oxide
synthetase in mammals, which leads to the characterization of the nitric oxide
synthase hemoprotein (bNOS) [26].
3.4 Staphylococcus aureus as a pro-inflammatory agent
The S. aureus contains molecules such as peptidoglycan and lipoteichoic acid,
potent stimulants for the production of cytosines such as TNF-α, IL-4, IL-6, IL-8,
IL-12, IL-1be, growth-regulated oncogene (GRO) alpha, and regulated upon activa-
tion, normal T-cell expressed, and secreted (RANTES). RANTES has a chemotactic
function to perform leukocyte recruitment to areas of infection in addition to
inducing tumor necrosis factor alpha and interleukin 1. Elevated levels can persist
for 7–14 days [27]. As we can observe, S. aureus activates in a very important way
the process of inflammation.
3.5 Staphylococcus aureus and blood stream infections in infective endocarditis
Circulatory blood stream infections (positive blood cultures) occur in patients
with intravascular prosthetic devices as the most common source of infections
related to health care [28]. MRSA was the most frequent pathogen in these types of
infections with a consistent increase in the isolates of MRSA [29–31]. In the EU,
epidemiological surveillance data on bloodstream infections show a marked vari-
ability among the member countries that make up a proportion of S. aureus that is
resistant to methicillin, ranging from less than 1% to more than 50%. In addition to
infections associated with health care, new MRSA strains have emerged in their
communities as human pathogens associated with livestock [32].
3.6 Endocardial endothelium and myocardial capillary endothelium
The anatomical and physiological barriers of cardiac protection such as the
endothelium can be compromised in its structure when areas of turbulence and
injury are generated, producing an area exposed to infection. The intracardiac
cavities have a cell layer called endocardial endothelium (EE) that covers the endo-
cardium of the atria, ventricles, and all their anatomical components (papillary
muscles, chordae tendineae, and heart valves). The EE acts as an active mechanism
of biological heart-blood barrier, since it interacts dynamically with cardiomyocytes
allowing direct communication and signaling between both types of cells. This
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electrochemical communication between the cells of the EE and the cardiomyocytes
allows a rapid intracellular electrochemical propagation and amplification of the
functional properties of the EE.
Signaling between cardiac endothelial cells (EE and myocardial capillary endo-
thelium) and cardiomyocytes influences cardiac growth, contractile performance,
and rhythmicity. The network of Purkinje fibers and the subendocardial neural
plexus (parasympathetic nervous system) is immediately below the endocardial
endothelium (EE) and participates in the endothelial control of cardiac rhythm.
Endothelin-1 (Et-1), nitric oxide (ON), prostaglandins (PGI2), prostacyclin (AI and
AII), angiotensin I and II, and vascular endothelial growth factor (VEGF) are
involved in these processes.
The endothelium that covers cardiac structures is at the vascular level, the
myocardial capillary, and the endocardium; its activation includes changes in the
endothelial phenotype as part of the physiological adaptive response to several
possible injuries and stressors. The dysfunction of the endothelium implies a
deregulated response that is not useful and that can be permanent.
One of the clinical disorders that selectively damage the endocardium and
subendocardial interstitial tissue is endocarditis. This entity causes activation of the
vascular and endocardial endothelial system, as well as poor adaptation or failure
characterized by hemodynamic abnormalities, neurohormonal imbalance, cytokine
expression, and endothelial dysfunction [33].
Infective endocarditis is an anatomoclinical entity characterized by microbial
infection of the valvular or parietal endothelium or both; it is located predominantly
on the left side of the heart, although it can also occur in the right (e.g., endovenous
drug), which produces inflammation, exudation, and proliferation of the endocar-
dium. The most characteristic lesion is the vegetation, constituted by an amorphous
mass of platelets and fibrin, of variable size, which contains multiple microorgan-
isms and scarce inflammatory cells (fibrinoplaquetary thrombus) [34]. This type of
lesions generates metastatic infection in other anatomical territories, for example,
the central nervous system, apostematous meningitis, myocarditis, pyelonephritis,
and splenic abscesses which are at risk of rupture [35, 36].
4. Clinical manifestations
The clinical manifestations of infective endocarditis are acute rapidly progres-
sive or subacute; the pathophysiological processes of both are explained by immu-
nological and vascular phenomena, such as inflammatory response, mediators of
inflammation triggered by a maladaptive response to an infectious process, aggre-
gation of immune complexes, infectious vasculitis, and peripheral microembolism
[34, 37]. Depending on the affected cardiac cavity (right/left) or valvular
system, the clinical manifestations will be due to the aforementioned
processes [38] (Table 1).
4.1 Anatomopathological changes
The anatomopathological changes due to the formation of vegetations in the
valvular ring and/or in the leaflets cause an anatomical alteration. If this anatomical
alteration generated by a vegetation prevents valvular closure, it will be expressed
as a murmur of valvular insufficiency and in severe cases such as microembolisms
septic and non-septic and cardiac failure [34, 37].
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4.2 Considerations on the cardiac cavity affected by infective endocarditis
The standard reference to corroborate the clinical diagnosis of IE is
transesophageal echocardiography since the transthoracic echocardiogram, even
when limited to native valves, decreases the diagnostic probability of IE [39].
Right and left endocarditis are two distinct entities that require different clinical
and surgical approaches. The diagnosis of endocarditis on the right side requires a
high index of clinical suspicion. It can occur with a history of intravenous drug use,
fever, and pulmonary infiltrates, although intravenous drug abuse is also a cause of
IE on the left side of the heart [36]. The information provided by echocardiography
is of prognostic and therapeutic value.
If the vegetation is <1.0 cm in diameter, it can be expected that antibiotic
therapy will resolve the infection; if the size of the vegetation determined by
echocardiography is ≥1.0 cm without response to treatment, surgical intervention
should be considered [40].
Surgical treatment in IE on the left side of the heart, for example, the mitral
valve, is indicated in patients with severe mitral regurgitation, even in the absence
of congestive heart failure, with mitral annular abscess, large vegetation >10 mm,
uncontrolled sepsis, and multiple embolisms [41]. Mitral valve (MV) replacement
has traditionally been considered as the standard treatment for MV endocarditis
that does not respond to antibiotic treatment.
However, the pioneering work of Dreyfus et al. surgery for repair of the mitral
valve with IE can be performed safely and is often associated with a better outcome
compared to mitral valve replacement [42, 43].
Patients, %
Sign
Fever 86–96
New murmur 48
Worsening of old murmur 20
Hematuria 26
Vascular embolic event 17
Splenomegaly 11
Splinter hemorrhages 8
Osler nodes 3
Janeway lesions 5
Roth spots 2
Complication
Stroke 17–20
Non-stroke embolization 23–33
Heart failure 14–33
Intracardiac abscess 14–20
New conduction abnormality 8
Murdoch et al. [38].
Table 1.
Clinical signs and complications of infective endocarditis.
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5. Role of immunogenetics in the physiopathology of sepsis and
infective endocarditis
5.1 Introduction
It has been largely recognized that infective processes have considerably differ-
ent patient-to-patient behavior in such a way that some patients respond well to the
treatment applied and some others end up developing a dysregulated immune
response known as sepsis [44], organ failure, and some even die from this process.
Infective endocarditis does not escape from this fact. Many variables, such as the
virulence of the pathogen and the quality of the treatment applied, among many
others, participate in an additive manner to conform the clinical outcomes of infec-
tions, and this helps to understand why a patient takes the road of success or failure
regarding the control of the septic process. One of the most recent advances in the
understanding of the pathophysiology of infective processes, including infective
endocarditis, is the demonstration that genetically determined differences in the
immune system of individuals are one of these many factors that determine the
phenotypic behavior and outcomes. Therefore, the next chapter section is dedicated
to explaining the existing evidence of the participation of immunogenetics in the
development of infective endocarditis and sepsis.
Recently, the concept of sepsis has been redefined as the result of a better
understanding of its pathophysiology, particularly regarding the early activation of
pro- and anti-inflammatory immune responses. As the third international consen-
sus definition of sepsis states, sepsis is a life-threatening organ dysfunction caused
by a dysregulated host response to an infection [45]. Then, if sepsis is dependent on
a dysregulated response, and this response is executed principally by the host
immune system, then genetically defined differences between individuals immune
system might play a role in the genesis of this syndrome and at least partially
explain why some patients take the road of sepsis and some others do not. This
hypothesis had long been existed, but it was until 1988 that the theory started
gaining scientific evidence of its existence, when Sørensen et al. [46] published
what is considered a landmark study with respect to this topic. In this article, the
authors studied the genetical influences on the principal causes of nonviolent pre-
mature death in the Danish population; to separate them from the environmental
influences, they studied a selected group of people that had been adopted early in
life. This was extracted from the Danish Adoption Registry and included adoptees
that were born between 1924 and 1926. They traced them up and demonstrated that
the death of a biologic parent from an infection before the age of 50 resulted in a
relative risk of death from infective causes in the adoptees of 4.5. Since this publi-
cation, a great number of studies have been conducted in an attempt to define the
specific genetic variations that determine these differences in outcome. This task
has resulted complex; as both pro- and anti-inflammatory responses contribute to
the outcome of septic processes, all genes encoding effector proteins in the bio-
chemical pathways of the inflammatory response to infection are potential candi-
dates to determine the genetical background responsible for the interindividual
differences aforementioned [47].
5.1.1 The study of single nucleotide polymorphism associations with sepsis and
IE outcomes.
The most studied specific type of genetic anomaly regarding to sepsis suscepti-
bility is the single nucleotide polymorphism (SNP); therefore, the largest body of
evidence comes from the study of this type of genetic variations. SNPs are defined
as frequent (occurring in >1% of the population) variations in the human DNA
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sequence [48] and consist in the exchange of a single base pair for another in a
specific location in the DNA sequence. They may occur within the exonic (coding)
or intronic (noncoding) region of the gene and can have different consequences
which include alteration of expression or structure of proteins and enzymes, intro-
duction of an alternative translation initiation codon or stop codon, and destabili-
zation of exonic mRNA [49]. Methodologically speaking, most studies are
association studies (case/control and cohort type), and two approaches have been
done. In the most common approach (which for purposes of this chapter section are
going to be called specific SNP association studies), the frequency of one or more
known SNPs present in genes coding defined molecular candidates involved in the
pro- or anti-inflammatory responses (e.g., alpha tumoral necrosis factor gene) is
compared between a specific phenotypically defined interest group (patients with a
confirmed specific infectious scenario as sepsis or IE) and a control group, usually
consisting of a group of healthy blood donors ideally with an ethnicity equal to the
interest group. If there are statistically significant differences in the frequency of
the SNPs between groups, authors take this as proof that such genetic differences
are implicated in the specific way that the study population responds to infection.
The other approach is a type of study called genome-wide association studies
(GWAS). As the previously described type of study, GWAS are association studies
(most frequently case–control studies) but differ in that the frequency of most
known SNPs is measured in the whole genome of the cases (infected group) and
controls (healthy blood donors). When a statistically significant difference is found,
authors take this as proof that such genetic variability is responsible for the differ-
ence in outcomes and then hypothesize, based in the location of the SNPs, about the
biological plausibility of the association given the gene that is affected.
5.2 The evidence in sepsis
A large number of specific SNP association studies have been conducted
respecting the most important effector molecules in response to sepsis and also
some GWAS.
5.3 Tumor necrosis factor alpha
In response to an infectious stimuli, such as lipopolysaccharides (LPS), tumor
necrosis factor α (TNF-α) is a cytokine that is released early mainly by macro-
phages, and it is a principal mediator of the inflammatory response to infection
which stimulates acute inflammation by its action on different cells, such as
endothelial cells and leukocytes [50].
Many studies have been done in an attempt to determine if specific SNPs in the
TNF alpha factor gene are implicated in sepsis susceptibility with conflicting results.
A recent meta-analysis from Zhang et al. [51] which included 23 articles that eval-
uated the effects of TNF-α rs1800629 and rs361525 polymorphisms on sepsis risk
found that TNF-α rs1800629 was associated with increased sepsis risk in the overall
population in four genetic models, including adenosine (A) vs. guanine (G)
(p < 0.001, odds ratio (OR) = 1.32), GA vs. GG (p < 0.001, OR = 1.46), GA + AA
vs. GG (p < 0.001, OR = 1.46), and carrier A vs. carrier G (p < 0.001, OR = 1.32).
These results suggest an implication of these genetic variations with an increased
susceptibility for sepsis development.
5.4 Tumor necrosis factor beta (TNF-β)
TNF-β is a cytokine produced by T lymphocytes similar to TNF-α and binds to
TNF receptors. It activates endothelial cells and neutrophils and is a mediator of
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acute inflammatory response, providing a link between T-cell activation
and inflammation. These effects are the same as those of TNF-α, consistent
with their binding to the same receptors. However, as the quantity of TNF-β is
much less than that of TNF-α made by lipopolysaccharide-stimulated
mononuclear phagocytes, TNF-β is not readily detected in the circulation. For
this reason, TNF-β is usually a local cytokine and not a mediator of systemic
injury. A single nucleotide polymorphism has been found at position +252 in the
first intron of the TNF-β gene and consists of a G in the wild-type allele
(TNFB1) and an A in the variant allele (TNFB2). Known as the Nco1
polymorphism, it has been proposed as a potentially influential locus in many
inflammatory conditions. Delongui et al. studied the association of the TNF-β Nco1
genetic polymorphism with susceptibility to sepsis in 60 patients diagnosed with
sepsis and in 148 healthy blood donors. Among the septic patients, the allelic
frequencies of TNFB1 and TNFB2 were 0.2833 and 0.7166, respectively, and they
differed from those observed in the blood donors (p = 0.02). The TNFB2 allele
frequency was higher in the septic patients than in the controls [OR = 1.65 (CI
95% 1.02–2.69), p = 0.0315], all this suggesting an implication in susceptibility
to sepsis [52].
5.5 Interleukin 10 (IL-10)
IL-10 has beneficial anti-inflammatory properties; however, an excess of
IL-10 has been reported to induce immunosuppression in bacterial sepsis.
Published data demonstrates that lower production of IL-10 from stimulated
peripheral blood mononuclear cells (PBMC) from septic patients is significantly
correlated with favorable disease outcome [53]. Stanilova et al. [54] investigated
the 1082 (A/G) polymorphism in the promoter of the IL-10 gene by measuring
IL-10 production from stimulated peripheral blood mononuclear cells (PBMC)
and to evaluate the relationship of this polymorphism with susceptibility to severe
sepsis and its outcome. They found that carriage of at least one copy of
IL-10-1082 G allele in sepsis patients and in healthy controls resulted in a statisti-
cally significant increase in IL-10 production from stimulated PBMC. Patients who
survived sepsis had a significant decrease of IL-10-1082 allele G frequency,
compared with controls (17 vs. 47.2%; p = 0.012). This suggests that this genetic
variation has an impact in IL-10 production and in the outcomes of septic
patients [55].
5.6 Interleukin-1 receptor antagonist gene (IL-1 Ra)
Interleukin 1β (IL-1β) is a potent pro-inflammatory cytokine implicated in the
development of chronic inflammatory disorders. IL-1β signaling is blocked by IL-1
Ra, a natural regulator of IL-1 cytokines. IL-1 Ra binds to the IL-1 receptor and
thereby prevents binding of both IL-1a and IL-1b [56]. F. Arnalich et al. aimed to
determine the influence of the polymorphism within the intron 2 of the IL-1RNa
(IL-RNa*) on the outcome of severe sepsis. A group of 78 patients with severe sepsis
(51 survivors and 27 non-survivors) was compared with a healthy control group of
130 blood donors and 56 patients with uncomplicated pneumonia. They found a
significant association between IL-1RN* polymorphism and survival. After
adjusting for age and APACHE II score, they did a multiple logistic regression
analysis that showed that patients’ homozygotes for the allele *2 had 647 times
more risk of death (95% CI 101–4147, p = 0.04). These authors concluded that
these genetic mutations might be implicated in an increased risk of death in septic
patients [57].
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5.7 High-mobility group box 1 protein (HMGB1)
HMGB1 is a pleiotropic cytokine that has been implicated in the
pathophysiology of systemic inflammatory response syndrome (SIRS) and sepsis.
HMGB1 is measurable in the systemic circulation in response to severe injury.
This protein has the propensity to bind to a variety of inflammatory mediators such
as lipopolysaccharide and pro-inflammatory cytokines, including IL-1. The role of
HMGB1 as an endogenous molecule facilitates immune responses and has an
important role in homeostasis between tissue and disease. HMGB1 is implicated
in the pathophysiology of a variety of inflammatory diseases, and it has been
found that variation in the HMGB1 gene is associated with mortality in patients
with systemic inflammatory response syndrome [58]. Kornblit et al. performed a
long-term, 4-year study comparing HMGB1 sequencing data in 239 intensive care
unit (ICU) patients with HMGB1 blood levels and clinical outcomes. The
promoter variant 1377delA was associated with a markedly reduced long-term
survival rate after ICU admission in SIRS patients. There was also a significant
interaction with a polymorphism within the coding region of the HMGB1 gene at
position 982 (C > T) in exon 4; carriers had an increased frequency of early
death from infection [59].
5.8 Toll-like receptor 2 (TLR2)
TLRs are a group of pattern recognition receptors. They play important roles in
regulating inflammatory reactions and activating adaptive immune response to
eliminate infective pathogens [60]. TLR2, a key member of TLR family, can recog-
nize a variety of bacterial lipoproteins. The mechanism of TLR2-recognizing
lipoproteins has been elucidated; after TLR2 recognizes lipoproteins, it activates
MyD88 adaptor-like protein and initiates a signaling pathway, which induces fur-
ther immune response [61]. This evidence puts TLR2 gene as an appealing candi-
date for determining sepsis risk. In a recent meta-analysis, Gao et al. [62] analyzed a
total of 12 studies (11 records) with 898 cases and 1517 controls examined to
determine the association between the TLR2 Arg753Gln polymorphism and sepsis
risk. The combined results of the overall comparison indicated that there were
significant associations between the TLR2 Arg753Gln polymorphism and sepsis risk
under the allele comparison model and the dominant model, respectively (for A vs.
G, OR 1.76, 95% CI 1.05–2.95, p = 0.03; for AA/GA vs. GG, OR 1.92, 95% CI
1.11–3.32, p = 0.02).
5.9 Genome-wide association study
Rautanen et al. [63] did a genome-wide association study in three independent
cohorts of white adult patients admitted to ICU with sepsis, severe sepsis, or septic
shock due to pneumonia or intra-abdominal infection (n = 2534 patients). The
primary outcome was 28-day survival. Results for the three cohorts of patients with
sepsis due to pneumonia were combined in a meta-analysis of 1553 patients. The
most significantly associated SNPs were genotyped in a further 538 white patients
with sepsis due to pneumonia (an independent fourth cohort), of whom 106 died.
In the genome-wide meta-analysis of three independent pneumonia cohorts, com-
mon variants in the FER gene were strongly associated with survival (p = 97  10–8;
OR 052 [95% CI 041–066]). Genotyping of the additional fourth cohort strength-
ened the evidence for association with survival (p = 56  10–8; OR 056 [045–
069]).
10
Infective Endocarditis
5.10 The evidence in infective endocarditis
There are many risk factors described for the development of IE; nevertheless
up to 30–50% of patients with this diagnosis does not have any known risk factor
[64]. Therefore, as in sepsis per se, there is thought to be immunogenetic influences
that affect the risk of development and outcomes in IE. However, in comparison
to sepsis, evidence of the immunogenetic influence on the susceptibility and out-
comes of IE is less robust. Golovkin et al. [65] hypothesized that inherited variation
in TLR and triggering receptor expressed on myeloid cells (TREMs) genes may
affect individual susceptibility to IE. They conducted a specific SNP study in which
the distribution of genotypes and alleles of the TLR1, TLR2, TLR4, TLR6, and
TREM-1 gene polymorphisms was investigated in 110 Caucasian subjects with IE
and 300 matched healthy blood donors. ORs with 95% CI were calculated. They
found that C/C genotype of the rs3775073 polymorphism within TLR6 gene was
associated with a decreased risk of IE (OR = 0.51, 95% CI = 0.26–0.97, p = 0.032)
according to the recessive model; however, there was no association between the
other investigated SNPs within TLR andTREM-1 genes and IE.
Moreau et al. [66] conducted a GWAS of 67 patients with definite native valve
S. aureus IE (cases) and 72 matched native valve patients with S. aureus bacteremia
but without IE (controls). Unfortunately, no SNPs were significantly associated
with S. aureus IE at the genome-wide level (p < 5  108). Four suggestive SNPs
(p < 0.00001) were located on one locus on chromosome 3, near the genes CLDN11
and SLC7A14. For all, the frequency of the minor allele was lower in cases than in
controls, suggesting a protective effect against S. aureus IE. The same association
was observed using an independent Danish verification cohort of Staphylococcus
aureus bacteremia with (n = 57) and without (n = 123) IE. An ex vivo analysis of
aortic valve tissues revealed that S. aureus IE associated SNPs mentioned above were
associated with significantly higher mRNA expression levels of SLC7A14, which is a
cationic amino acid transporter protein. These results suggest an IE-protective
effect of SNPs on chromosome 3 during S. aureus bacteremia. The authors con-
cluded that the effects of protective minor alleles may be mediated by increasing
expression levels of SLC7A14 in valve tissues.
6. Inflammation and oxidative stress
The modern mitochondria have an evolution of more than a billion years, orig-
inating as an invading Eubacterium in early eukaryotic cells. The knowledge of the
structure, functionality, and the similarities of the DNA between mitochondria
and bacteria strongly prove the endosymbiotic origin of the mitochondria. Of the
1000 or more mitochondrial proteins, only 13 are encoded by the mitochondrial
genome, the rest is transcribed and translated into the nuclear genome and
transported to the inner mitochondrial membrane [67].
In the heart the populations of mitochondria include subsarcolemmal mitochon-
dria, which are more susceptible to injury. Subsarcolemmal mitochondria provide
energy for membrane-related processes, including signal transduction, ion
exchange, and substrate transport, whereas the intermyofibrillar mitochondria
more directly support muscle contraction [68].
The mitochondrial oxidative phosphorylation process is responsible for the
conversion of macronutrient energy (e.g., glucose, fatty acids, and amino acids)
into ATP through a set of coordinated and highly coupled reactions where the
macronutrients are oxidized and the oxygen is reduced to water and adenosine
diphosphate (ADP) is phosphorylated to ATP.
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6.1 Chemiosmotic hypothesis
In the chemiosmotic hypothesis [69], the proton gradient is formed by removing
H+ from the interior (matrix), while the negative charges remain inside, largely as
OHˉ ions; the pH on the outer face of the membrane (intermembrane space) can
reach a pH of 5.5, while the pH just at the inner side (matrix) of the same can reach
8.5; this gradient is 3 pH units. Recall that the pH is equal to - log. of [H+], and
therefore 3 units of pH mean that the ΔH+ = 1000 between both faces of the
membrane, that is to say there are 1000 times more H+ in the intermembrane space
than on the side of the membrane that is in contact with the mitochondrial matrix
(Figure 1).
The process begins when carbon substrates enter the tricarboxylic acid cycle
through acetyl CoA or anaplerotic reactions. Oxidation of these substrates generates
reducing equivalents in the form of NADH and FADH2, which provide electron
fluxes through the complexes of the respiratory chain, complex I (NADH dehydro-
genase) and complex II (succinate dehydrogenase). The flow of electrons through
complexes I and II converges in complex III (ubiquinone-cytochrome c reductase),
together with electrons from electron transfer flavoproteins (beta oxidation),
although the mobile electron carrier coenzyme Q as second mobile electron carrier
transfers electrons to the IV complex (cytochrome c oxidase) where they are finally
transferred to oxygen, producing water. A gradient of protons (an electrochemical
gradient) through the inner mitochondrial membrane is generated by the action of
electron transport through complexes I, III, and IV. The potential energy of this
gradient is exploited by the V (ATP synthase) complex to phosphorylate ADP to
ATP [71]. It is clear that the maintenance of the mitochondrial membrane potential
through the transport of electrons is critical for the proper function of the organelle
and, therefore, of the cell and of ascending form of organs and systems.
Figure 1.
The creation of a proton gradient (∆H+) in the intermembrane space is produced by the chain of electron
transport and the synthesis of ATP synthase, which is maintained by the electrons that pass from the reducing
equivalents (NADH, FADH2) to the cytochromes along the inner membrane of the mitochondria. ATP synthase
uses that gradient to generate ATP. The two processes are associated with the inner membrane of the
mitochondria in the mitochondrial crests. Note that the enzymes of the citric acid cycle and β-oxidation are
contained in mitochondria, together with the respiratory chain, which collects and transports reducing
equivalents, directing them to their final reaction with oxygen to form water, and the machinery for oxidative
phosphorylation, the process by which the liberated free energy is trapped as high-energy phosphate. Source:
Botham and Mayes [70].
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6.2 Reactive oxygen species
In the process of mitochondrial respiration, the generation of reactive oxygen
species (ROS) is generally a cascade of reactions that begins with the production of
superoxide O•2. The oxidative stress is defined as an imbalance that favors ROS
production on antioxidant defenses; most ROS are products of mitochondrial respi-
ration. Approximately 1–2% of the molecular oxygen consumed during the process
of mitochondria respiration is converted to superoxide radicals. Briefly, the reduc-
tion of an electron of molecular oxygen produces a relatively stable intermediate,
the superoxide anion (O•2); the importance of this is that it serves as the precursor
to most ROS.
Therefore, it is very important to take into account the sources that generate it.
There is evidence that most of the O•2 generated by intact mammalian mitochon-
dria in vitro is produced by complex I. The production of superoxide—O•2—is
mainly carried out in the inner mitochondrial membrane (IMM) together with
complex III [72, 73]. On the other hand, the production of O•2 is stimulated by the
presence of succinate (substrate of complex II) [74]. Ubiquinone as part of the
respiratory chain binds complexes I with II and II with III which is also important
for the formation of O•2 by complex III [75]. Oxidation of ubiquinone—Q cycle—
and unstable semiquinone also generates O•2 (Figure 2).
The Q cycle couples electron transfer to proton transport in complex III elec-
trons are passed from QH2 to cytochrome c via complex III (Q-cytochrome c
oxidoreductase) as described in Figure 2.
QH2 þ 2cyt coxidized þ 2H
þ matrix (1)
Q þ 2cyt creduced þ 4Hþ intermembrane space (2)
Figure 2.
The flavin adenine dinucleotide (FAD) can be reduced in reactions involving the transfer of two electrons (to
form FMNH2 or FADH2), but they can also accept one electron to form the semi Quinone. Electron-transferring
flavoprotein (ETF). Fe-S, iron–sulfur proteins (nonheme iron proteins). The Fe-S take part in single-electron
transfer reactions in which one Fe atom undergoes oxidoreduction between Fe2+ and Fe3+. Coenzyme Q (Q)
(also called ubiquinone) (complex I). Cytochrome c, Q-cytochrome c oxidoreductase (complex III), which
passes the electrons on to cytochrome c; and cytochrome c oxidase (complex IV), which completes the chain,
passing the electrons to O2 and causing it to be reduced to H2O. Q and cytochrome c are mobile. Q diffuses
rapidly within the membrane, while cytochrome c is a soluble protein. Mn-SOD, manganese superoxide
dismutase.
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Superoxide rapidly dismutates into hydrogen peroxide spontaneously or at a low
pH is catalyzed by superoxide dismutase. Other elements in the cascade of ROS
generation are small molecules derived from oxygen, like the following: hydroxyl
(OH•), peroxyl (RO•2), and alkoxyl (RO•) and certain non-radicals that are oxidiz-
ing agents and/or are easily converted to radicals, such as hypochlorous acid
(HOCl), ozone (O3), singlet oxygen (½O2), and hydrogen peroxide (H2O2).
Nitrogen-containing oxidants, such as nitric oxide (NO), are called reactive nitro-
gen species (RNS), and the Fenton reaction catalyzed by iron leads to the generation
of hydroxyl radical [76, 77]. The dismutation of superoxide anions by superoxide
dismutases results in the production of H2O2. The mitochondria contribute 20–30%
of the stable cytosolic concentration of H2O2 [78]; the subsequent interaction of
H2O2 and O•2 in a Haber-Weiss reaction, or the cleavage of H2O2 driven by Fe
2+-
(or Cu2+), can generate the highly reactive hydroxyl radical (OH•).
The Haber-Weiss reaction [79] may occur as a consequence of oxidative stress.
The reaction is catalyzed by the iron in oxidation state (III); the first step of the
catalytic cycle is produced by the reduction of the ferric cation to ferrous cation:
Fe3þ þ •O2 ! Fe2þ þO2 (3)
The second step is a reaction from Fenton:
Fe2þ þH2O2 ! Fe3þ þOH þ •OH (4)
6.3 Superoxide dismutases
Briefly, superoxide dismutases (SOD) are a group of metalloenzymes
(containing Fe, Mn, or Cu and Zn) that catalyze the disproportionation of superox-
ide free radical (2O•) to form hydrogen peroxide and oxygen as shown below:
2•O2 þ 2Hþ⇔H2O2 þO2 (5)
In some cell types, CuZnSOD is present in the mitochondrial intermembrane
space, where it can convert O•2 to H2O2, thus permitting further diffusion into the
cytosol.
Superoxide rapidly dismutates into hydrogen peroxide spontaneously or at a low
pH is catalyzed by sequential actions of superoxide dismutase (SOD), and catalase
converts superoxide into oxygen and water. Other elements in the cascade of ROS
generation are small molecules derived from oxygen, which also include oxygen
radicals [80].
Because ROS are biologically damaging, they need to be metabolized to prevent
the damage they can cause when interacting with other compounds, for which the
cell counts with mechanisms that avoid it like SOD. However, when the formation
of ROS increases, they have the capacity to deteriorate mitochondrial function and
jeopardize cell survival in different ways, where the mitochondrion seems to be
responsible for regulating apoptosis [81]. ROS are a major threat to encode, transfer,
and transport electrons and generate ATP by directly damaging mitochondrial DNA
(mtDNA) which encodes 13 polypeptides, 12 transfer RNAs (tRNAs), and 2 ribo-
somal RNAs (rRNAs). All of them are essential in the chain of transport of electrons
for the production of ATP, so when interacting with them, oxidative phosphoryla-
tion and therefore energy genesis is compromised [67]. ROS, and the release of
proapoptotic proteins from the intermembrane space of mitochondria, triggers the
activation of cell death.
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7. Nicotinamide adenine dinucleotide phosphate oxidase
7.1 NADPH oxidase
The heart has the highest oxygen uptake rate in the human body, and the
oxygen consumption is normally 8–13 mL 100 gˉ1 minˉ1 at rest [82]. The cellular
sources in the genesis of ROS in the heart include cardiac myocytes, endothelial
cells, and neutrophils. Within cardiac myocytes, ROS can be produced by several
mechanisms, including the transport of mitochondrial electrons, NADPH oxidase
(nicotinamide adenine dinucleotide phosphate oxidase), and xanthine dehydroge-
nase/xanthine oxidase. To meet the high demand for ATP synthesis, cardiac
myocytes therefore have the highest volume density of mitochondria in the entire
human body.
NADPH oxidase with its isoforms generically called NOX is the major source of
ROS (reactive oxygen species) in biological systems. NOX proteins are involved in a
plethora of pathophysiological conditions, so it is important to note that the func-
tions of NOX proteins in different tissues are influenced by the activity of other
oxidases and peroxidases, such as myeloperoxidase, xanthine oxidase, and
hemoxygenase [83].
In the heart, the cardiomyocyte NADPH oxidase seems to be the main source of
production of ROS from the heart in failure [84, 85].
NADPH oxidases are present in phagocytes and in a wide variety of non-
phagocytic cells. NADPH generates superoxide by transferring electrons from
NADPH into the cell through the membrane and coupling them to molecular
oxygen to produce superoxide anion. Structurally, NADPH oxidase is an enzyme
that has several components: it includes two integral membrane proteins, the
glycoprotein gp. 1 Phox and the adapter protein p22 (phox), which together form
the heterodimeric b558 flavocytochrome that form the nucleus of the enzyme.
During the resting state, the multidomain regulatory subunits p40P (phox), p47
(phox), and p67 (Phox) are located in the cytosol organized as a complex.
Activation of phagocytic NADPH oxidase occurs through a complex series of
protein interactions.
The products that activate it are angiotensin II, endothelin-1, TNF-α, and
mechanical forces. The cardiomyocyte NADPH oxidase and any other NADPH
oxidase when stimulated generates large amounts of (O•2), which dismutes to H2O2;
both in the tissue presence of iron and H2O2, increase the production of ROS, lead
to the production of the HO• radical; these are highly reactive and can induce
peroxidative damage of molecules within reach such as lipids, proteins, carbohy-
drates, nucleic acids, and membranes, resulting in the increase of reactive
substances thiobarbituric acid (TBARS) in patients with heart failure.
This suggests that some pro-inflammatory products can activate a pathway
to generate oxidative stress damage through the NADPH oxidase and increase
the biological damage to the heart by ROS which correlates with left
ventricular dysfunction [86]. Even more, the fact that NADPH oxidase is
activated by pro-inflammatory products suggests a link with the genesis of
oxidative stress.
Of the infectious processes in the heart on the balance of oxidants and antioxi-
dants in the myocardium little is known. IE in which heart valves are usually
affected, generating refractory congestive heart failure, is accompanied by a very
important inflammatory response, both local and systemic with high circulating
concentrations of IL-6, IL-2R, and IL-1β [87]. In the case of infective endocarditis,
the interaction of the infectious agent and its products (chemotactic, formylated,
and lipopolysaccharide peptides) with monocytes and polymorphonuclear cells can
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increase the production of ROS through the activation of NADPH oxidase, second-
ary to the inflammatory state.
IE induces an increase of pro-inflammatory cytokines, being able to stimulate
ROS production in the myocardium and peroxidative damage to several molecules.
The substances reactive to thiobarbituric acid (TBAR), in a study comparing cardiac
tissue from patients with IE and patients with valvular heart disease (VHD) of
rheumatic etiology; TBARs were increased 10 times more in IE than their controls
with VHD [88].
8. Inducible nitric oxide synthase
In sepsis, endotoxins and cytokines stimulate the expression of inducible nitric
oxide synthase (iNOS) and the overproduction of nitric oxide (NO) in various
tissues; it also stimulates the excessive activity of NADPH oxidase that facilitates
the expression of iNOS to produce large amounts of NO. The NADPH oxidases
derived from ROS by activating the Jak2-IRF1 and JNK-AP1 pathways are necessary
for the induction of iNOS. The main mechanism that regulates the activity of
iNOS is the modulation of the transcription of the iNOS gene. The NO derived from
iNOS and its metabolite peroxynitrite can contribute to the pathological alterations
observed in sepsis, such as endothelial dysfunction, hypotension, and multiple
organ failure [89].
The peroxynitrite anion ONOO
H2O2 þNO2 ! ONOO þH2O (6)
•O2 þ •NO! ONO2 (7)
9. Metabolome and proteome
The composition of metabolites such as amino acids, intermediate products of the
Krebs cycle, and acylcarnitines (metabolome) and protein complement expressed in
cells, tissues, or body fluids (proteome) of survivors of sepsis and non-survivors was
analyzed in patients who studied with sepsis by three different pathogens, S.
pneumoniae, S. aureus, or E. coli. The main differences between survivors and non-
survivors were those highlighted in their metabolome and proteome. For example,
nine proteins involved in the transport of fatty acids were decreased in non-survivors
of sepsis, suggesting a defect in β-oxidation. The nonacceptance and nonuse of fatty
acids by the mitochondria led to an accumulation of acylcarnitines in the plasma;
another predictive marker is that glycolysis and gluconeogenesis were also markedly
different. Survivors of sepsis showed decreased levels of citrate, malate, glycerol,
glycerol 3-phosphate, phosphate, and glucogenic and ketogenic amino acids, while
non-survivors showed elevated levels of citrate, malate, pyruvate, dihydroxyacetone,
lactate, phosphate, and gluconeogenic amino acids [90]. That is to say that the
pathways for the transport of fatty acids, as well as glycolysis and gluconeogenesis,
are damaged, so the substrate is low, and they are not used by the mitochondria.
10. Acetylome
Acetylome analysis identified a subpopulation of mitochondrial proteins that
was sensitive to changes in the NADH/NAD+ ratio. Hyperacetylation induced by
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mitochondrial dysfunction is a positive regulator of pathological remodeling in the
heart of mice with primary or acquired mitochondrial dysfunction, as well as in
humans with heart failure. Hyperacetylation of mitochondrial malate–aspartate
shuttle (MAS) proteins impaired the transport and oxidation of cytosolic NADH in
the mitochondria, resulting in altered cytosolic redox state and energy deficiency.
Furthermore, acetylation of oligomycin-sensitive conferring protein at lysine-70 in
adenosine triphosphate synthase complex promoted its interaction with cyclophilin
D and sensitized the opening of mitochondrial permeability transition pore. There
are two different mechanisms that point to the proteins of hyperacetylation, i.e.,
MAS and the regulators of mitochondrial permeability transition pore (mPTP),
which mediate an increase in heart failure. Both could be fixed by normalizing the
NAD+ redox balance either genetically or pharmacologically [91].
11. Q and cytochrome c
Q and cytochrome c (Cytc) are mobile. Q diffuses rapidly within the membrane,
while cytochrome c is a soluble protein that contains a peptide sequence located at
the C-terminus of the protein [92] that allows it to cross the cell membranes in a
nontraditional way. This property of Cytc was used in a study in mice, which were
subject to ligation and cecal puncture; they underwent sepsis and damage to mito-
chondrial respiration, which was restored with the injection i.v. of Cytc [93]. The
treatment led to an uptake of Cytc into the cardiomyocytes, and survival increased
from 15% for the sepsis control group to about 50% in mice that were also injected
with Cytc [94].
12. Deregulated apoptosis and multiple organ failure
The death of cells of the immune system by deregulated apoptosis contributes to
the dysfunction of the immune system and multiple organ failure (MOF) which is
observed in sepsis. The immune cells most affected by this dysregulated apoptotic
cell death appear to be lymphocytes [95]. Extensive lymphocytic apoptosis medi-
ated by caspase-3 in sepsis may contribute to impaired immune response in septic
patients [96]. Lymphocyte loss occurs by both death receptor and mitochondrial-
mediated apoptosis, suggesting that there may be multiple triggers for lymphocyte
apoptosis [97, 98].
Apoptosis in the immune system is a pathological event in sepsis which has been
considered a therapeutic goal. Studies on sepsis in experimental animals suggest
that the loss of lymphocytes during sepsis may be due to deregulated apoptosis and
that it appears to be secondary to a variety of mediators that carry out both “intrin-
sic” and “extrinsic” cell death pathways.
In experimental animals, lymphocyte apoptosis is frequently seen 12 h after the
onset of experimental polymicrobial sepsis in the thymus, spleen, and lymphoid
tissues associated with the intestine. It has been suggested that deregulated lym-
phocytic apoptosis results in reduced septic survival through loss of lymphocytes,
resulting in multiple organ failure and ultimately death. Lymphocyte apoptosis in
the thymus appears to occur 4 h after the onset of sepsis and is independent of the
effects of endotoxin or death receptors. Apoptosis in the spleen appears to be
particularly important in mortality from sepsis, by an increase of the splenic apo-
ptosis of lymphocytes in experimental animals after the cecal ligation and puncture
(CLP) which results in a reduced survival [99].
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In septic humans apoptosis does not seem to be generalized, since in these
patients only extensive lymphocytic apoptosis was demonstrated, which suggests a
damaged immune response, suggesting that other mechanisms apart from cell death
participate in the conditions associated with mortality [100]. For example, hyper-
glycemia induces the expression of leukocyte adhesion molecules, such as the
intercellular adhesion molecule (ICAM) and vascular cell adhesion molecule
(VCAM), which is suppressed by treatment with insulin. Another example is the
impairment induced by hyperglycemia in the function of neutrophils, including
chemotaxis, phagocytosis, and respiratory function, which is attenuated with
insulin [101].
13. Conclusions
As we observed, the epidemiology of IE has changed over time. S. aureus is
currently the most important pathological agent as a cause of IE [4, 102]. The age
group with greater participation is the older adult due to their comorbidities, espe-
cially cardiac ones, with the need for valve prosthesis placement, and vascular
approach for the placement of cardiac pacemakers.
The existence of an immunogenetic influence in the risk and outcomes of infec-
tious diseases has been well stablished. In the cases of IE and sepsis, investigation is
ongoing to clearly define the specific genetic anomalies that contribute to this
influence. The study of SNPs has been a good start in the understanding of the
phenomena; nevertheless at the light of the information derived from their study,
they do not seem sufficient to explain the whole participation of genetics in the
sepsis and IE equation. Other types of genetic abnormalities might also participate,
and it might be worth exploring [103]. Even though there is a large body of studies
with positive results, there are also lots of contradictory and conflicting findings
that make it difficult to make definitive conclusions. Even more, according to a
systematic review made to determine the methodological quality of SNP association
studies with sepsis, most of the studies could improve a lot methodologically
speaking in terms of control group selection, genetic assay technique, study
blinding, statistical interpretation, study replication, study size, and power.
Finally, the sequence of events that begin with an infectious state, such as IE,
alerts and promotes inflammation through the immune system, both cellular and
humoral to eliminate the infectious agent; however, this has the ability to evade the
immune system.
In its evolution, the germ also generated the possibility of survival through the
acquisition of resistance to external agents, such as antibiotics, which can perpetu-
ate the septic process, increasing the production of reactive O2 species both locally
(cell-mitochondria) and systemic level (neutrophil-monocytes-macrophage-
endothelium) together with the products that generate the interaction infectious
agent-immune system.
The activity of antioxidant enzymes is exceeded, so that ROS cannot be elimi-
nated, generating a state of oxidative stress, with a profound effect on the mito-
chondrial level by breaking the chain of electron transport, and, consequently, the
genesis of the energy is compromised.
The repercussion of this sequence of events, both at the cardiac level and at the
systemic level, is manifested by the failure of one or several organs.
In a schematic way, the sequence of events of a patient with IE who has a severe
evolution and finally dies of multiple organ failure is shown (Figure 3).
Different studies explore areas of compromise such as metabolome and prote-
ome in which it is observed that glycolysis, gluconeogenesis, and fatty acid
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transport are damaged, so the substrate is low and the few substrates are not used
by the mitochondria, which generates attention in processes to be repaired.
In another (acetylome) the possibility of normalizing the NAD + redox
balance is observed both genetically and pharmacologically in the treatment of
heart failure [91].
The observations of the behavior of cytochrome c, being a mobile complex
molecule and crossing cell membranes, made it possible for cytochrome c to enter
into cardiomyocytes to improve mitochondrial respiration, improving the survival
of septic mice [92–94]. This open a very attractive opportunity in the treatment of
septic patients with heart failure as in IE when in the future we use complex
molecules, i.v., in the treatment of these patients.
There are still many areas in which it is necessary to continue researching in
the clinical area as well as in the bacteriological, biochemical, and biomolecular
areas in addition to other types of tools to observe systemic inflammation, through
mathematical modulation and systems-based models of inflammation [104, 105],
and the severity of a septic patient due to the complexity of losing the cardiac
bioelectrical signal and how it recovers the complexity if the patient survives the
septic event have also been considered [106].
Figure 3.
Schematic representation of the sequence of events of a patient with IE who has a severe evolution and finally
dies of multiple organ failure.
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Acronyms and abbreviations
MRSA methicillin-resistant Staphylococcus aureus
HssRS hem sensor system
hrtAB hem regulator transporter
bNOS nitric oxide synthase hemoprotein
TNF tumor necrosis factor alpha
IL interleukin
HMGB1 high-mobility group box 1 protein
GRO alpha growth-regulated oncogene
RANTES regulated upon activation, normal T-cell expressed, and
secreted
EE endocardial endothelium
Et-1 endothelin-1
ON nitric oxide
PG prostaglandins
VEGF vascular endothelial growth factor
SNP single-nucleotide polymorphism
GWAS genome-wide association studies
LPS lipopolysaccharides
A adenosine
G guanine
PBMC peripheral blood mononuclear cells
IL-RNa* The interleukin 1receptor antagonist gene
APACHE II score acute physiology and chronic health evaluation
SIRS systemic inflammatory response syndrome
ICU intensive care unit
TLR toll-like receptor
MyD88 adaptor-like protein
FER gene tyrosine-protein kinase
TREMs triggering receptor expressed on myeloid cells
ADP adenosine diphosphate
NADH nicotinamide adenine dinucleotide phosphate
FADH flavin adenine dinucleotide
ROS reactive oxygen species
IMM inner mitochondrial membrane
OH• hydroxyl
RO•2 peroxyl
RO• alkoxyl
20
Infective Endocarditis
HOCl hypochlorous acid
O3 ozone
½O2 singlet oxygen
H2O2 hydrogen peroxide
RNS reactive nitrogen species
SOD superoxide dismutases
2O•2 superoxide free radical
CuZnSOD copper, zinc-superoxide dismutase
mtDNA mitochondrial DNA
tRNAs transfer RNAs
rRNAs ribosomal RNAs
NOX NADPH oxidase generically called
phox adapter protein p22
TBARS reactive substances thiobarbituric acid
iNOS inducible nitric oxide synthase
NO nitric oxide
JNK-AP1 Jak2-IRF1 pathway genes (IFNGR1, IFNGR2, JAK1, JAK2,
STAT1, IRF1)
MOF multiple organ failure
MODS multi-organ dysfunction syndrome
CLP cecal ligation and puncture
ICAM intercellular adhesion molecule
VCAM vascular cell adhesion molecule
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